References
Babiarz, B. S.; Hathaway, H. J. Hormonal control of the expression of antibody-defined lactosaminoglycans in the mouse uterus. Biol. Reprod. 39:699–706; 1988.
Donehower, L. A.; Harvey, M.; Slagle, B. L., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221; 1992.
Gordon, D. A.; Miesfeld, R. L. Immortalization of rat ventral prostate epithelial cells using simian virus 40 T antigen. In: Celis, J. E. ed. Cell Biology, A Laboratory Handbook. London: Academic Press; 1992:251–257.
Greco, T. L.; Furlow, J. D.; Duello, T. M., et al. Immunodetection of estrogen receptors in fetal and neonatal female mouse reproductive tracts. Endocrinology 129:1326–1332; 1991.
James, K.; Bell, G. T. Human monoclonal antibody production. Current status and future prospects. J. Immunol. Methods 100:5–40; 1987.
Kastan, M. B.; Zhan, Q.; El-Deiry, W. S., et al. A mammalian cell cycle check point pathway utilizing p53 and GADD 45 is defective in ataxia-telangiectasia. Cell 71:587–597; 1992.
Lane, D. P. p53, guardian of the genome. Nature 358:15–16; 1992.
Stapleton, P.; Takayama, Y.; Hartshorn, A., et al. Tumor progression following transformation of murine monocytes by v-myc: acquisition of immortalization and tumorigenicity. Oncogene 6:807–817; 1991.
Tsukada, T.; Tomooka, Y.; Takai, S., et al. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313–3322; 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanazono, M., Tomisawa, H., Tomooka, Y. et al. Establishment of uterine cell lines from p53-deficient mice. In Vitro Cell.Dev.Biol.-Animal 33, 668–671 (1997). https://doi.org/10.1007/s11626-997-0121-3
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11626-997-0121-3